Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis

Withdrawn before enrolling · Not applicable

Conditions studied: Arthritis, Rheumatoid

In brief

This research will evaluate a multifaceted patient-centered intervention in a sample of socioeconomically disadvantaged Hispanic adults with rheumatoid arthritis (RA) that capitalizes on a partnership between the extended rheumatology healthcare team and each patient in order to promote understanding, uptake and adherence to the principles of treat-to-target strategy. The primary hypothesis of this study is that the addition of a multifaceted intervention incorporating integrated multidisciplinary rheumatologic care, nurse-directed self-management education and supportive follow-up, and technology-based at home RA symptom monitoring and reporting to clinical guideline-based care will increase RA remission rate at 6 months.

Key facts

Study ID

NCT02720874

Run by

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

People needed

0

Starts

2025-01-01

Expected to finish

2025-04-14

Last updated by the study team

2026-07-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Reside in Greater Los Angeles area and receive rheumatologic care at the adult rheumatology clinic at Harbor-UCLA Medical Center in Torrance, California
• Fulfill the 2010 American College of Rheumatology revised diagnostic criteria for RA
• Have at least moderate disease activity as indicated by a Clinical Disease Activity Index (CDAI) score >10 and Routine Assessment Patient Index Data (RAPID3) score >2
• Be able and willing to provide written informed consent and to adhere to the study visit schedule and other protocol
• Availability of a touch-tone landline or mobile telephone
• Of self-identified Hispanic/Latino descent

You may not qualify if…

• Known irreversible articular damage, including subluxations, arthrodesis, fusion, or prosthesis
• Functional class IV as defined by the American College of Rheumatology Classification of Functional Status in rheumatoid arthritis
• Overlapping autoimmune or mixed connective tissue syndromes
• Serious medical conditions, including: chronic infection, advanced or decompensated heart failure, higher than class II chronic kidney disease, cancer (unless in remission for period of 5 years or more), or any uncontrolled medical condition that is deemed by the investigators to interfere with the study protocol
• At risk for suicide

Where it is running

• The Lundquist Institute at Harbor-UCLA Medical Center — Torrance, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.